Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
More stories
Mitchell
Article
Workers’ Comp Data: About 25% of COVID-19 Claims Have Associated Medical Costs
Data analysis by Aarthi Thiruvengadam. In 2020, the workers’ compensation industry endured many changes due to the COVID-19 pandemic, incl
Mitchell
Article
The Evolution of Claims Automation
COVID-19 has hastened the pace of digital transformation in many industries, including auto insurance.
Mitchell
Article
COVID—A Year Later
How the World (May Be) Forever Changed by COVID-19 One year ago this week, our Company sent out the first set of employee notices to adop
Mitchell
Article
Current Used Vehicle Market Conditions: Q4 2020
December 2020 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Chief Economist, KAR Global.
Auto Casualty
Article
Drug of the Month: Insights Into COVID-19 Vaccines and Workers' Comp
COVID-19 vaccination efforts continue to progress, after the
Mitchell
Article
A Look Back at 2020 Trends in Auto Insurance
It has been a year since the United States and Canada first felt the effects of COVID-19.